Myriad Genetics (MYGN)'s 30-day implied volatility (IV30) was 101.3% at the close on October 22, 2026, down from 115.8% the day before, against a 52-week range of 37.2% to 128.2%. Its 20-day historical volatility was 78.5%.
Data as of October 22, 2026.